746 related articles for article (PubMed ID: 24369114)
1. Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial.
Chow E; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JS; Brundage MD; Nabid A; Tissing-Tan CJ; Oei B; Babington S; Demas WF; Wilson CF; Meyer RM; Chen BE; Wong RK
Lancet Oncol; 2014 Feb; 15(2):164-71. PubMed ID: 24369114
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
Sahgal A; Myrehaug SD; Siva S; Masucci GL; Maralani PJ; Brundage M; Butler J; Chow E; Fehlings MG; Foote M; Gabos Z; Greenspoon J; Kerba M; Lee Y; Liu M; Liu SK; Thibault I; Wong RK; Hum M; Ding K; Parulekar WR;
Lancet Oncol; 2021 Jul; 22(7):1023-1033. PubMed ID: 34126044
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Aluwini S; Pos F; Schimmel E; van Lin E; Krol S; van der Toorn PP; de Jager H; Dirkx M; Alemayehu WG; Heijmen B; Incrocci L
Lancet Oncol; 2015 Mar; 16(3):274-83. PubMed ID: 25656287
[TBL] [Abstract][Full Text] [Related]
4. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05).
Roos DE; Turner SL; O'Brien PC; Smith JG; Spry NA; Burmeister BH; Hoskin PJ; Ball DL;
Radiother Oncol; 2005 Apr; 75(1):54-63. PubMed ID: 15878101
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
Hartsell WF; Scott CB; Bruner DW; Scarantino CW; Ivker RA; Roach M; Suh JH; Demas WF; Movsas B; Petersen IA; Konski AA; Cleeland CS; Janjan NA; DeSilvio M
J Natl Cancer Inst; 2005 Jun; 97(11):798-804. PubMed ID: 15928300
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Aluwini S; Pos F; Schimmel E; Krol S; van der Toorn PP; de Jager H; Alemayehu WG; Heemsbergen W; Heijmen B; Incrocci L
Lancet Oncol; 2016 Apr; 17(4):464-474. PubMed ID: 26968359
[TBL] [Abstract][Full Text] [Related]
8. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
Pielkenrood BJ; van der Velden JM; van der Linden YM; Bartels MMT; Kasperts N; Verhoeff JJC; Eppinga WSC; Gal R; Verlaan JJ; Verkooijen HML
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):358-367. PubMed ID: 33333200
[TBL] [Abstract][Full Text] [Related]
9. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
Erlandsson J; Holm T; Pettersson D; Berglund Å; Cedermark B; Radu C; Johansson H; Machado M; Hjern F; Hallböök O; Syk I; Glimelius B; Martling A
Lancet Oncol; 2017 Mar; 18(3):336-346. PubMed ID: 28190762
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.
Chow E; Meyer RM; Ding K; Nabid A; Chabot P; Wong P; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; Brundage M; DeAngelis C; Wong RKS
Lancet Oncol; 2015 Nov; 16(15):1463-1472. PubMed ID: 26489389
[TBL] [Abstract][Full Text] [Related]
11. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party.
Radiother Oncol; 1999 Aug; 52(2):111-21. PubMed ID: 10577696
[TBL] [Abstract][Full Text] [Related]
12. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study.
Steenland E; Leer JW; van Houwelingen H; Post WJ; van den Hout WB; Kievit J; de Haes H; Martijn H; Oei B; Vonk E; van der Steen-Banasik E; Wiggenraad RG; Hoogenhout J; Wárlám-Rodenhuis C; van Tienhoven G; Wanders R; Pomp J; van Reijn M; van Mierlo I; Rutten E
Radiother Oncol; 1999 Aug; 52(2):101-9. PubMed ID: 10577695
[TBL] [Abstract][Full Text] [Related]
13. Multifraction radiotherapy for palliation of painful bone metastases: 20 Gy versus 30 Gy.
Valeriani M; Scaringi C; Blasi L; Carnevale A; De Sanctis V; Bonome P; Bracci S; Marrone G; Minniti G; Enrici RM
Tumori; 2015; 101(3):318-22. PubMed ID: 25908049
[TBL] [Abstract][Full Text] [Related]
14. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
Raje N; Terpos E; Willenbacher W; Shimizu K; García-Sanz R; Durie B; Legieć W; Krejčí M; Laribi K; Zhu L; Cheng P; Warner D; Roodman GD
Lancet Oncol; 2018 Mar; 19(3):370-381. PubMed ID: 29429912
[TBL] [Abstract][Full Text] [Related]
15. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?
Fairchild A; Barnes E; Ghosh S; Ben-Josef E; Roos D; Hartsell W; Holt T; Wu J; Janjan N; Chow E
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1501-10. PubMed ID: 19464820
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases.
Kaasa S; Brenne E; Lund JA; Fayers P; Falkmer U; Holmberg M; Lagerlund M; Bruland O
Radiother Oncol; 2006 Jun; 79(3):278-84. PubMed ID: 16793154
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Wilkins A; Mossop H; Syndikus I; Khoo V; Bloomfield D; Parker C; Logue J; Scrase C; Patterson H; Birtle A; Staffurth J; Malik Z; Panades M; Eswar C; Graham J; Russell M; Kirkbride P; O'Sullivan JM; Gao A; Cruickshank C; Griffin C; Dearnaley D; Hall E
Lancet Oncol; 2015 Dec; 16(16):1605-16. PubMed ID: 26522334
[TBL] [Abstract][Full Text] [Related]
18. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.
Chow E; Danjoux C; Wong R; Szumacher E; Franssen E; Fung K; Finkelstein J; Andersson L; Connolly R
Radiother Oncol; 2000 Sep; 56(3):305-14. PubMed ID: 10974379
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration.
Arcangeli G; Giovinazzo G; Saracino B; D'Angelo L; Giannarelli D; Arcangeli G; Micheli A
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1119-26. PubMed ID: 9869238
[TBL] [Abstract][Full Text] [Related]
20. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials.
Sze WM; Shelley MD; Held I; Wilt TJ; Mason MD
Clin Oncol (R Coll Radiol); 2003 Sep; 15(6):345-52. PubMed ID: 14524489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
